James Kong, MD
Interventional Cardiology · Cincinnati, OHNPI 1407823040
Payments from drug & device makers
Across 58 payments — averaging $277.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Asahi Intecc USA, Inc.$7K
- Medtronic$7K
- Abbott$1K
- Boston Scientific$319
- Abiomed$279
- Philips North America LLC$227
- plus $408 from 8 others
What the payments were for
- Speaking & faculty fees$13,23089%
- Food & beverage$1,57611%
- Education$240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Asahi Intecc USA, Inc. | 9 | $6,754 |
| Medtronic | 4 | $6,735 |
| Abbott | 7 | $1,351 |
| Boston Scientific | 5 | $319 |
| Abiomed | 3 | $279 |
| Philips North America LLC | 2 | $227 |
| Cardinal Health 200 LLC | 16 | $200 |
| Biotronik Inc. | 5 | $83 |
| Astellas Pharma US Inc | 1 | $31 |
| Chiesi USA, Inc. | 2 | $24 |
| Cathworks, Inc. | 1 | $22 |
| Reflow Medical Inc | 1 | $21 |
| Medline Industries LP | 1 | $18 |
| Cardiovascular Systems Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Resolute$6,730
- ASAHI PTCA Guide Wire$6,500
- Impella$253
- Lasers$227
- PERIPHERAL VASCULAR$196
- MAMBA$130
How this compares
$16,074 in reported general payments places this provider in the 65th percentile of 256 interventional cardiology providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 224 | $247,285 |
| EntrestoSacubitril/Valsartan | 83 | $84,073 |
| XareltoRivaroxaban | 61 | $77,325 |
| Repatha SureclickEvolocumab | 47 | $48,284 |
| JardianceEmpagliflozin | 41 | $45,071 |
| Praluent PenAlirocumab | 43 | $33,148 |
| Ezetimibe | 184 | $4,796 |
| Rosuvastatin Calcium | 263 | $3,754 |
| Atorvastatin Calcium | 450 | $3,740 |
| Metoprolol Succinate | 191 | $2,847 |
| ClopidogrelClopidogrel Bisulfate | 285 | $2,680 |
| Ranolazine ErRanolazine | 26 | $2,207 |
| Torsemide | 143 | $2,042 |
| Carvedilol | 217 | $1,359 |
| Chlorthalidone | 77 | $1,132 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Cincinnati
- Santiago GarciaCincinnati$3.6M
- Dean KereiakesCincinnati$3.4M
- Joseph ChooCincinnati$1.9M
- Timothy HenryCincinnati$1.3M
- John CorlCincinnati$793K
- Ian SarembockCincinnati$266K
- Puvi SeshiahCincinnati$230K
- Steven RudickCincinnati$216K
- Imran ArifCincinnati$127K
- Jonathan RappCincinnati$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.